TapewireFind a company

person · Reporting owner

WALSH GEORGE J III

Disclosed activity across 1 company

Tapewire entity
43402
SEC CIK
0001207140

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
CHEMED CORPCHE · Entity 3723DirectorMay 29, 2026May 29, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CHEMED CORP

Report date May 29, 2026 · Filed May 29, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Capital StockSEC Table I · non-derivativeDirect3,209 Reported balance After 2026-05-29 transaction · row 1
1 source row

Row 1 · 2026-05-29 · Sale · Disposed 500 · Balance 3,209

Capital StockSEC Table I · non-derivativeIndirectspouse434 Reported balance Holding disclosure · report date 2026-05-29 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 434

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 29, 2026 Filed May 29, 2026 19:42 UTC CHEMED CORP CHE · Entity 3723 SaleCapital Stock 500 $437.83 $218,915.00
Disclosure

SEC source: 0001193125-26-248086 · ownership.xml · nonDerivative · entry 1

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,209

Read SEC document
May 18, 2026 Filed May 19, 2026 14:03 UTC CHEMED CORP CHE · Entity 3723 GrantCapital Stock 386 $440.77 $170,137.22
Disclosure

SEC source: 0001193125-26-229860 · ownership.xml · nonDerivative · entry 1

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,709

F1 · acquired: Award of stock

Read SEC document
August 04, 2025 Filed Aug 5, 2025 19:24 UTC CHEMED CORP CHE · Entity 3723 PurchaseCapital Stock 200 $417.10 $83,420.00
Disclosure

SEC source: 0000950170-25-102898 · ownership.xml · nonDerivative · entry 1

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,523

Read SEC document
May 19, 2025 Filed May 20, 2025 16:42 UTC CHEMED CORP CHE · Entity 3723 GrantCapital Stock 277 $579.04 $160,394.08
Disclosure

SEC source: 0000950170-25-075023 · ownership.xml · nonDerivative · entry 1

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,323

F1 · acquired: Award of stock

Read SEC document
September 26, 2024 Filed Sep 27, 2024 15:17 UTC CHEMED CORP CHE · Entity 3723 SaleCapital Stock 400 $597.47 $238,988.00
Disclosure

SEC source: 0000950170-24-109796 · ownership.xml · nonDerivative · entry 1

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,046

Read SEC document
August 21, 2024 Filed Aug 22, 2024 16:06 UTC CHEMED CORP CHE · Entity 3723 SaleCapital Stock 200 $577.95 $115,590.00
Disclosure

SEC source: 0000950170-24-099742 · ownership.xml · nonDerivative · entry 1

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,446

Read SEC document
May 20, 2024 Filed May 21, 2024 16:46 UTC CHEMED CORP CHE · Entity 3723 GrantCapital Stock 284 $564.34 $160,272.56
Disclosure

SEC source: 0000950170-24-062734 · ownership.xml · nonDerivative · entry 1

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,646

F1 · kind: Award of stock

Read SEC document
May 15, 2023 Filed May 16, 2023 17:17 UTC CHEMED CORP CHE · Entity 3723 Grantcapital stock 294 $545.69 $160,432.86
Disclosure

SEC source: 0001209191-23-029725 · doc4.xml · nonDerivative · entry 1

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,362

F1 · kind: Award of stock

Read SEC document
December 30, 2022 Filed Jan 26, 2023 17:21 UTC CHEMED CORP CHE · Entity 3723 Purchasecapital stock 4 $509.34 $2,037.36
Disclosure

SEC source: 0001209191-23-004981 · doc5.xml · nonDerivative · entry 1

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,068

F1 · kind: Additional shares purchased in Savings & Retirement Plan

Read SEC document
May 16, 2022 Filed May 17, 2022 18:25 UTC CHEMED CORP CHE · Entity 3723 Grantcapital stock 262 $496.25 $130,017.50
Disclosure

SEC source: 0001209191-22-029536 · doc4.xml · nonDerivative · entry 1

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,064

F1 · kind: Award of stock

Read SEC document
May 17, 2021 Filed May 18, 2021 16:30 UTC CHEMED CORP CHE · Entity 3723 Grantcapital stock 270 $482.66 $130,318.20
Disclosure

SEC source: 0001209191-21-033414 · doc4.xml · nonDerivative · entry 1

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,802

F1 · kind: Award of stock

Read SEC document
May 03, 2021 Filed May 4, 2021 17:52 UTC CHEMED CORP CHE · Entity 3723 Salecapital stock 626 $480.31 $300,674.06
Disclosure

SEC source: 0001209191-21-029755 · doc4.xml · nonDerivative · entry 1

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,532

Read SEC document
May 18, 2020 Filed May 19, 2020 16:22 UTC CHEMED CORP CHE · Entity 3723 Grantcapital stock 279 $466.43 $130,133.97
Disclosure

SEC source: 0001209191-20-030342 · doc4.xml · nonDerivative · entry 1

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,158

F1 · kind: Award of stock

Read SEC document
March 02, 2020 Filed Mar 3, 2020 15:30 UTC CHEMED CORP CHE · Entity 3723 Salecapital stock 2 $445.12 $890.24
Disclosure

SEC source: 0001209191-20-014888 · doc4.xml · nonDerivative · entry 7

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,879

Read SEC document
March 02, 2020 Filed Mar 3, 2020 15:30 UTC CHEMED CORP CHE · Entity 3723 Salecapital stock 10 $444.98 $4,449.80
Disclosure

SEC source: 0001209191-20-014888 · doc4.xml · nonDerivative · entry 6

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,881

Read SEC document
March 02, 2020 Filed Mar 3, 2020 15:30 UTC CHEMED CORP CHE · Entity 3723 Salecapital stock 44 $444.75 $19,569.00
Disclosure

SEC source: 0001209191-20-014888 · doc4.xml · nonDerivative · entry 5

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,891

Read SEC document
March 02, 2020 Filed Mar 3, 2020 15:30 UTC CHEMED CORP CHE · Entity 3723 Salecapital stock 45 $445.24 $20,035.80
Disclosure

SEC source: 0001209191-20-014888 · doc4.xml · nonDerivative · entry 4

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,935

Read SEC document
March 02, 2020 Filed Mar 3, 2020 15:30 UTC CHEMED CORP CHE · Entity 3723 Salecapital stock 199 $445.05 $88,564.95
Disclosure

SEC source: 0001209191-20-014888 · doc4.xml · nonDerivative · entry 3

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,980

Read SEC document
March 02, 2020 Filed Mar 3, 2020 15:30 UTC CHEMED CORP CHE · Entity 3723 Salecapital stock 1,053 $444.76 $468,332.28
Disclosure

SEC source: 0001209191-20-014888 · doc4.xml · nonDerivative · entry 2

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,179

Read SEC document
March 02, 2020 Filed Mar 3, 2020 15:30 UTC CHEMED CORP CHE · Entity 3723 Salecapital stock 3,595 $406.10 $1,459,929.50
Disclosure

SEC source: 0001209191-20-014888 · doc4.xml · nonDerivative · entry 1

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,232

Read SEC document
August 07, 2019 Filed Aug 7, 2019 16:24 UTC CHEMED CORP CHE · Entity 3723 Purchasecapital stock 500 $412.86 $206,430.00
Disclosure

SEC source: 0001209191-19-044924 · doc4.xml · nonDerivative · entry 1

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,827

Read SEC document
May 20, 2019 Filed May 22, 2019 16:02 UTC CHEMED CORP CHE · Entity 3723 Grantcapital stock 257 $331.69 $85,244.33
Disclosure

SEC source: 0001209191-19-031943 · doc4.xml · nonDerivative · entry 1

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,327

F1 · kind: Award of stock

Read SEC document
May 06, 2019 Filed May 6, 2019 17:46 UTC CHEMED CORP CHE · Entity 3723 Salecapital stock 646 $326.83 $211,132.18
Disclosure

SEC source: 0001209191-19-027662 · doc4.xml · nonDerivative · entry 1

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,070

Read SEC document
February 25, 2019 Filed Feb 25, 2019 15:13 UTC CHEMED CORP CHE · Entity 3723 Salecapital stock 1,000 $328.07 $328,070.00
Disclosure

SEC source: 0001209191-19-012855 · doc4.xml · nonDerivative · entry 1

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,663

Read SEC document
December 05, 2018 Filed Mar 15, 2019 16:42 UTC CHEMED CORP CHE · Entity 3723 Purchasecapital stock 1 $312.85 $312.85
Disclosure

SEC source: 0001209191-19-019634 · doc4.xml · nonDerivative · entry 14

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,716

F1 · kind: Shares acquired through Dividend Reinvestment Program

Read SEC document
December 04, 2018 Filed Mar 15, 2019 16:42 UTC CHEMED CORP CHE · Entity 3723 Purchasecapital stock 6 $313.94 $1,883.64
Disclosure

SEC source: 0001209191-19-019634 · doc4.xml · nonDerivative · entry 13

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,715

F1 · kind: Shares acquired through Dividend Reinvestment Program

Read SEC document
September 05, 2018 Filed Mar 15, 2019 16:42 UTC CHEMED CORP CHE · Entity 3723 Purchasecapital stock 1 $320.30 $320.30
Disclosure

SEC source: 0001209191-19-019634 · doc4.xml · nonDerivative · entry 12

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,709

F1 · kind: Shares acquired through Dividend Reinvestment Program

Read SEC document
September 04, 2018 Filed Mar 15, 2019 16:42 UTC CHEMED CORP CHE · Entity 3723 Purchasecapital stock 6 $322.63 $1,935.78
Disclosure

SEC source: 0001209191-19-019634 · doc4.xml · nonDerivative · entry 11

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,708

F1 · kind: Shares acquired through Dividend Reinvestment Program

Read SEC document
June 22, 2018 Filed Mar 15, 2019 16:42 UTC CHEMED CORP CHE · Entity 3723 Purchasecapital stock 1 $322.87 $322.87
Disclosure

SEC source: 0001209191-19-019634 · doc4.xml · nonDerivative · entry 10

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,702

F1 · kind: Shares acquired through Dividend Reinvestment Program

Read SEC document
June 21, 2018 Filed Mar 15, 2019 16:42 UTC CHEMED CORP CHE · Entity 3723 Purchasecapital stock 5 $322.21 $1,611.05
Disclosure

SEC source: 0001209191-19-019634 · doc4.xml · nonDerivative · entry 9

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,701

F1 · kind: Shares acquired through Dividend Reinvestment Program

Read SEC document
May 21, 2018 Filed May 23, 2018 18:03 UTC CHEMED CORP CHE · Entity 3723 Grantcapital stock 255 $333.75 $85,106.25
Disclosure

SEC source: 0001209191-18-032530 · doc4.xml · nonDerivative · entry 1

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,663

F1 · kind: Award of stock

Read SEC document
March 21, 2018 Filed Mar 15, 2019 16:42 UTC CHEMED CORP CHE · Entity 3723 Purchasecapital stock 1 $280.98 $280.98
Disclosure

SEC source: 0001209191-19-019634 · doc4.xml · nonDerivative · entry 8

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,696

F1 · kind: Shares acquired through Dividend Reinvestment Program

Read SEC document
March 20, 2018 Filed Mar 15, 2019 16:42 UTC CHEMED CORP CHE · Entity 3723 Purchasecapital stock 6 $280.48 $1,682.88
Disclosure

SEC source: 0001209191-19-019634 · doc4.xml · nonDerivative · entry 7

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,695

F1 · kind: Shares acquired through Dividend Reinvestment Program

Read SEC document
December 06, 2017 Filed Mar 15, 2019 16:42 UTC CHEMED CORP CHE · Entity 3723 Purchasecapital stock 1 $249.14 $249.14
Disclosure

SEC source: 0001209191-19-019634 · doc4.xml · nonDerivative · entry 6

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,689

F1 · kind: Shares acquired through Dividend Reinvestment Program

Read SEC document
December 05, 2017 Filed Mar 15, 2019 16:42 UTC CHEMED CORP CHE · Entity 3723 Purchasecapital stock 7 $241.14 $1,687.98
Disclosure

SEC source: 0001209191-19-019634 · doc4.xml · nonDerivative · entry 5

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,688

F1 · kind: Shares acquired through Dividend Reinvestment Program

Read SEC document
September 07, 2017 Filed Mar 15, 2019 16:42 UTC CHEMED CORP CHE · Entity 3723 Purchasecapital stock 1 $197.22 $197.22
Disclosure

SEC source: 0001209191-19-019634 · doc4.xml · nonDerivative · entry 4

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,681

F1 · kind: Shares acquired through Dividend Reinvestment Program

Read SEC document
September 05, 2017 Filed Mar 15, 2019 16:42 UTC CHEMED CORP CHE · Entity 3723 Purchasecapital stock 9 $196.45 $1,768.05
Disclosure

SEC source: 0001209191-19-019634 · doc4.xml · nonDerivative · entry 3

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,680

F1 · kind: Shares acquired through Dividend Reinvestment Program

Read SEC document
June 26, 2017 Filed Jun 26, 2017 15:19 UTC CHEMED CORP CHE · Entity 3723 Purchasecapital stock 500 $204.08 $102,040.00
Disclosure

SEC source: 0001209191-17-041800 · doc4.xml · nonDerivative · entry 2

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,408

Read SEC document
June 23, 2017 Filed Jun 26, 2017 15:19 UTC CHEMED CORP CHE · Entity 3723 Purchasecapital stock 500 $205.03 $102,515.00
Disclosure

SEC source: 0001209191-17-041800 · doc4.xml · nonDerivative · entry 1

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,908

Read SEC document
June 19, 2017 Filed Mar 15, 2019 16:42 UTC CHEMED CORP CHE · Entity 3723 Purchasecapital stock 1 $209.35 $209.35
Disclosure

SEC source: 0001209191-19-019634 · doc4.xml · nonDerivative · entry 2

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,671

F1 · kind: Shares acquired through Dividend Reinvestment Program

Read SEC document
June 15, 2017 Filed Mar 15, 2019 16:42 UTC CHEMED CORP CHE · Entity 3723 Purchasecapital stock 7 $206.10 $1,442.70
Disclosure

SEC source: 0001209191-19-019634 · doc4.xml · nonDerivative · entry 1

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,670

F1 · kind: Shares acquired through Dividend Reinvestment Program

Read SEC document
May 15, 2017 Filed May 16, 2017 19:17 UTC CHEMED CORP CHE · Entity 3723 Grantcapital stock 418 $203.52 $85,071.36
Disclosure

SEC source: 0001209191-17-032594 · doc4.xml · nonDerivative · entry 2

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,408

F2 · kind: Award of stock

Read SEC document
March 31, 2017 Filed May 16, 2017 19:17 UTC CHEMED CORP CHE · Entity 3723 Purchasecapital stock 16 $183.92 $2,942.72
Disclosure

SEC source: 0001209191-17-032594 · doc4.xml · nonDerivative · entry 1

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,990

F1 · kind: Shares acquired through Dividend Reinvestment Program

Read SEC document
December 30, 2016 Filed Feb 8, 2017 17:09 UTC CHEMED CORP CHE · Entity 3723 Purchasecapital stock 6 $159.48 $956.88
Disclosure

SEC source: 0001209191-17-008559 · doc5.xml · nonDerivative · entry 2

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · spouse

Disclosed balance after: 428

F1 · kind: Shares acquired through Dividend Reinvestment Program

Read SEC document
December 30, 2016 Filed Feb 8, 2017 17:09 UTC CHEMED CORP CHE · Entity 3723 Purchasecapital stock 80 $159.48 $12,758.40
Disclosure

SEC source: 0001209191-17-008559 · doc5.xml · nonDerivative · entry 1

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,974

F1 · kind: Shares acquired through Dividend Reinvestment Program

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.